EGP 56,700
Avg. Salary
Avg. Hourly Rate

Average additional compensation:

EGP 13,500

Bonus

EGP 2,250

Profit Sharing

EGP 24,452

Commission

What am I worth?
How should I pay?

The average pay for a Sales Representative, Pharmaceuticals is {{pay}} per hour.

The average pay for a Sales Representative, Pharmaceuticals is EGP 56,700 per year.

EGP 0.00
10%
EGP 0.00
50%
EGP 0.00
90%
MEDIAN EGP 0.00
EGP 32k
10%
EGP 57k
50%
EGP 259k
90%
MEDIAN EGP 56,700
EGP 32,209 - EGP 259,326
EGP 32K
EGP 57K
EGP 260K
MEDIAN: EGP 56,700
10%
50%
90%
EGP 0EGP 259K
Salary EGP 32,209 - EGP 259,326
Bonus EGP 13,500
Profit Sharing EGP 2,250
Commission EGP 24,452
Total Pay (?
XTotal Pay combines base annual salary or hourly wage, bonuses, profit sharing, tips, commissions, overtime pay and other forms of cash earnings, as applicable for this job. It does not include equity (stock) compensation, cash value of retirement benefits, or the value of other non-cash benefits (e.g. healthcare).
)
EGP 33,866 - EGP 259,326
  • Country: Egypt
  • Currency: EGP
  • Updated: 9 Dec 2018
  • Individuals Reporting: 30

Job Description for Sales Representative, Pharmaceuticals

Sales representatives in the pharmaceutical industry have a number of responsibilities, including calling on existing and potential clients to establish new accounts, obtain orders, service existing accounts, and implement brand strategies intended to convey the company's marketing message. They must also adjust the content of sales presentations to be client-specific and reflect any changes in products, services, policies, or competitive development.

Read More...

Sales Representative, Pharmaceuticals Job Listings

Pay Difference by Location

5%

National Average: EGP 68,870

Larger city markers indicate a job is popular in that location.

Key Stats for Sales Representative, Pharmaceuticals

Gender

Female
25 %
Male
75 %
Less than 1 year
30%
1-4 years
63%
5-9 years
7%

Gender

Female
25 %
Male
75 %

Common Health Benefits

medical benefits
Medical: 74%
dental benefits
Dental: 42%
vision benefits
Vision: 42%
no benefits
None: 26%